Automated Early Warning Score (EWS) Wearable Technology: Sourcing Medical-Grade Continuous Monitoring Platforms

An Automated Early Warning Score (EWS) Wearable is a medically certified multi-sensor device worn on the wrist or body that continuously measures vital signs (such as heart rate, heart rate variability, respiration rate, SpO2, skin temperature, and activity) without manual intervention. Unlike traditional spot-check tools (such as standalone blood pressure cuffs or pulse oximeters used during nursing rounds every 4–8 hours), an automated EWS wearable captures vital sign trends 24/7. It automatically calculates established clinical risk scores—such as the National Early Warning Score (NEWS2) or Modified Early Warning Score (MEWS)—and transmits live data to central nursing dashboards, immediately flagging subtle physiological deterioration hours before a critical event occurs.

For deployment in acute care hospital wards, emergency departments, and formal remote patient monitoring programs, an EWS wearable must possess official medical device regulatory approvals rather than consumer wellness classification. In Europe, the device must be certified under the EU Medical Device Regulation (CE-MDR Class IIa/IIb) audited by an accredited Notified Body (such as Kiwa 0560). In the United States, the platform requires FDA 510(k) clearance for continuous multi-parameter monitoring. Additionally, the manufacturer’s quality system must be certified under ISO 13485, and all digital cloud processing must comply strictly with GDPR (Europe) and HIPAA (USA) privacy frameworks.

In standard general wards, nurses spend up to 20–30% of their shift measuring vitals manually, manually calculating points on paper or digital charts, and typing values into the EMR. This process is susceptible to human calculation error and transcription delay. The Corsano CardioWatch automated EWS system continuously derives the physiological parameters, applies clinical NEWS2 scoring logic automatically in real-time, and surfaces aggregated risk levels onto central telemetry displays. Nursing teams are freed from manual data entry, enabling them to focus on direct patient care while receiving instant alerts if a patient’s score trends upward.

Yes. A major differentiator of the Corsano CardioWatch 287 platform is its IP-free raw data access architecture. While many commercial wearables restrict access to proprietary derived metrics, Corsano provides open API and SDK access to uncompressed, high-frequency raw sensor data—including raw Photoplethysmography (PPG in green, red, and infrared spectra at up to 128 Hz), raw single-lead Electrocardiogram (ECG), raw 3-axis Accelerometer (ACC), skin temperature, and Galvanic Skin Response (GSR). Pharmaceutical researchers, university hospitals, and medical AI companies use these raw waveforms to construct proprietary digital biomarkers, validate custom algorithms, and train machine learning models for sepsis, cardiac arrest, and stress prediction.

The Corsano system features an enterprise-grade integration framework built on industry-standard communication protocols including HL7 and FHIR (Fast Healthcare Interoperability Resources) APIs. Vital sign measurements, aggregated trend data, and automated EWS calculations are pushed securely from the Corsano Cloud gateway into hospital information systems (HIS) and electronic medical records (EMR). Furthermore, mobile SDKs for iOS and Android allow hospital-customized mobile applications to pair directly with the CardioWatch 287 bracelet for seamless ward or home onboarding.

Alarm fatigue is a critical concern for hospital nursing directors. Corsano mitigates false alarms through a multi-layered technological approach: first, multi-wavelength PPG signals are correlated continuously with 3-axis accelerometer motion data to filter out movement artifacts; second, algorithms utilize temporal windowing and signal quality index (SQI) verification before generating escalation triggers; third, hospital ward administrators can configure customized alarm delay thresholds and multi-parameter combination rules (e.g., requiring both elevated heart rate and dropped respiration rate sustained for 3 minutes before triggering a high-priority alert).

Single-use adhesive chest patches create ongoing recurring disposable costs (often $30–$80 per patch changed every 3 to 7 days), leading to high operating expenditure for hospitals over time. Single-use patches also present skin irritation risks during extended wear. In contrast, the Corsano CardioWatch 287-2B is a durable, reusable medical bracelet designed for multi-year clinical life. It features a biocompatible, cleanable strap and magnetic rapid charging. This reusable capital equipment model significantly lowers the total cost per patient day, providing superior financial return on investment (ROI) for hospital procurement teams.

Yes. The CardioWatch 287 platform is optimized for continuous care continuum pathways. A patient admitted to a general ward is fitted with a CardioWatch bracelet. Upon discharge, the patient takes the exact same wearable home, connecting it to a dedicated home gateway hub or mobile app. Clinicians monitor the patient's continuous automated EWS trends remotely via the Corsano web portal, enabling early identification of post-operative complications or heart failure exacerbation, thereby dramatically reducing 30-day hospital readmission rates.